Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

Objective To assess the eligibility of patients participating in DISCOVER (a 3-year, prospective, observational study program of 15 992 patients with type 2 diabetes [T2D] initiating a second-line glucose-lowering therapy across 38 countries) for four cardiovascular outcomes trials (CVOTs) of sodium...

Full description

Saved in:
Bibliographic Details
Main Authors: Jesús Medina, Kamlesh Khunti, Stéphane Pintat, Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Eric Wittbrodt, Filip Surmont
Format: Article
Language:English
Published: BMJ Publishing Group 2019-05-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/7/1/e000627.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items